Heme biocrystallization

Heme biocrystallization is a vital detoxification process employed by blood-feeding parasites, most notably Plasmodium falciparum, to neutralize toxic heme released during host hemoglobin digestion (Hempelmann, 2007, PMID: 17307108). Within the parasite's acidic digestive vacuole, free ferriprotoporphyrin IX (heme) is converted into an insoluble, chemically inert crystalline polymer known as hemozoin, or malaria pigment (Egan, 2008, PMID: 18343315). This process is essential for parasite survival, as free heme induces oxidative stress, generates reactive oxygen species, and causes membrane lysis. Antimalarial drugs, particularly the quinoline class including chloroquine and quinine, target this pathway by binding to the surface of growing hemozoin crystals or forming complexes with free heme, thereby inhibiting further crystallization (Sullivan et al., 1996, PMID: 8637561). The resulting accumulation of toxic free heme leads to the death of the parasite, making this process one of the most successful and clinically validated targets in the history of antimalarial chemotherapy (Coronado et al., 2014, PMID: 24753355). Understanding the biophysical mechanisms of crystal growth remains a priority for overcoming widespread drug resistance associated with mutations in parasite transporter proteins like PfCRT.

Other names

Hemozoin formationHeme detoxificationFerriprotoporphyrin IX crystallizationMalaria pigment formation

Inhibition of hemozoin crystal growth by binding to the crystal faces or forming toxic complexes with free ferriprotoporphyrin IX, leading to parasite membrane damage and oxidative stress.